 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Analyst Coverage
| Analyst | Firm |
|---|---|
| Matthew Jacobson, MD | BDR Research Group |
| Adam Cutler | Canaccord Adams |
| Eric Schmidt, PhD | Cowen and Company |
| David Steinberg | Deutsche Bank |
| Charles Duncan, PhD | JMP Securities |
| Juan Sanchez, MD | Ladenburg Thalmann |
| Gary Nachman | Leerink Swann & Company |
| John Newman, PhD | Oppenheimer & Co., Inc. |
| Patricia L. Bank | Wedbush Morgan Securities |
Cadence Pharmaceuticals, Inc. is followed by the analyst(s) listed above. This list may not be all-inclusive. Please note that any opinions, estimates or forecasts regarding Cadence Pharmaceuticals, Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cadence Pharmaceuticals, Inc. or its management. Cadence Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
| Stock Quote |
|---|
| CADX - (NASDAQ)
$10.05 - 0.01 Nov 6, 2009 4:13 PM ET |
Quotes delayed at
least 20 minutes.
Information provided
by eSignal.